JAGX
Jaguar Health Inc
NASDAQ · Pharmaceuticals
$0.67
+0.08 (+13.12%)
Open$0.59
Previous Close$0.59
Day High$0.68
Day Low$0.59
52W High$41.33
52W Low$26.25
Volume—
Avg Volume747.2K
Market Cap2.50M
P/E Ratio13.05
EPS$2.90
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+7,049.3% upside
Current
$0.67
$0.67
Target
$47.90
$47.90
$35.39
$47.90 avg
$54.68
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 820.8K | 728.2K | 878.3K |
| Net Income | 214.7K | 171.9K | 200.8K |
| Profit Margin | 26.2% | 23.6% | 22.9% |
| EBITDA | 270.0K | 249.9K | 289.1K |
| Free Cash Flow | 118.6K | 132.1K | 184.4K |
| Rev Growth | +12.4% | -5.9% | +16.6% |
| Debt/Equity | 0.42 | 0.52 | 0.37 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |